HomeCompareCI vs ZBH

CI vs ZBH: Dividend Comparison 2026

CI yields 2.36% · ZBH yields 1.08%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CI wins by $133.46M in total portfolio value
10 years
CI
CI
● Live price
2.36%
Share price
$258.08
Annual div
$6.09
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$133.48M
Annual income
$123,432,595.24
Full CI calculator →
ZBH
ZBH
● Live price
1.08%
Share price
$88.62
Annual div
$0.96
5Y div CAGR
0.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.2K
Annual income
$118.64
Full ZBH calculator →

Portfolio growth — CI vs ZBH

📍 CI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCIZBH
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CI + ZBH cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CI pays
ZBH pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CI
Annual income on $10K today (after 15% tax)
$200.58/yr
After 10yr DRIP, annual income (after tax)
$104,917,705.95/yr
ZBH
Annual income on $10K today (after 15% tax)
$92.08/yr
After 10yr DRIP, annual income (after tax)
$100.84/yr
At 15% tax rate, CI beats the other by $104,917,605.11/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CI + ZBH for your $10,000?

CI: 50%ZBH: 50%
100% ZBH50/50100% CI
Portfolio after 10yr
$66.75M
Annual income
$61,716,356.94/yr
Blended yield
92.46%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CI right now

CI
Analyst Ratings
1
Strong
31
Buy
7
Hold
Consensus: Buy
Price Target
$325.83
+26.3% upside vs current
Range: $300.00 — $375.00
Altman Z
2.7
Piotroski
7/9
ZBH
Analyst Ratings
17
Buy
21
Hold
3
Sell
Consensus: Hold
Price Target
$105.60
+19.2% upside vs current
Range: $89.00 — $122.00
Altman Z
1.7
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CI buys
9
ZBH buys
0
PoliticianChamberTickerTypeAmountDate
Julie Johnson🏢 House$CI▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$CI▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$CI▼ Sell$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$CI▼ Sell$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$CI▼ Sell$1,001 - $15,0002025-09-29
Julie Johnson🏢 House$CI▼ Sell$1,001 - $15,0002025-09-25
Ro Khanna🏢 House$CI▲ Buy$1,001 - $15,0002025-09-05
Julie Johnson🏢 House$CI▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$CI▼ Sell$1,001 - $15,0002025-08-05
Jared Moskowitz🏢 House$CI▲ Buy$1,001 - $15,0002025-05-15
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCIZBH
Forward yield2.36%1.08%
Annual dividend / share$6.09$0.96
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%0.2%
Portfolio after 10y$133.48M$21.2K
Annual income after 10y$123,432,595.24$118.64
Total dividends collected$132.70M$1.1K
Payment frequencyquarterlyquarterly
SectorHealthcareHealthcare
Analyst consensusBuyHold
Analyst price target$325.83$105.60

Year-by-year: CI vs ZBH ($10,000, DRIP)

YearCI PortfolioCI Income/yrZBH PortfolioZBH Income/yrGap
1← crossover$11,172$471.95$10,809$108.54+$363.00CI
2$12,940$985.53$11,675$109.86+$1.3KCI
3$15,979$2,133.55$12,603$111.13+$3.4KCI
4$22,022$4,924.66$13,598$112.34+$8.4KCI
5$36,250$12,686.29$14,663$113.51+$21.6KCI
6$77,820$39,032.84$15,804$114.62+$62.0KCI
7$239,893$156,625.47$17,026$115.69+$222.9KCI
8$1,159,158$902,472.79$18,335$116.71+$1.14MCI
9$9,391,197$8,150,897.78$19,736$117.70+$9.37MCI
10$133,481,176$123,432,595.24$21,236$118.64+$133.46MCI

CI vs ZBH: Complete Analysis 2026

CIHealthcare

The Cigna Group provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Full CI Calculator →

ZBHHealthcare

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Full ZBH Calculator →
📬

Get this CI vs ZBH comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CI vs SCHDCI vs JEPICI vs OCI vs KOCI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.